Document is current
Any future updates will be listed below
-
Authors
Stravalaci, Matteo https://orcid.org/0000-0002-5636-4204
Pagani, Isabel
Paraboschi, Elvezia Maria
Pedotti, Mattia
Doni, Andrea
Scavello, Francesco
Mapelli, Sarah N. https://orcid.org/0000-0002-0129-2055
Sironi, Marina
Perucchini, Chiara
Varani, Luca
Matkovic, Milos
Cavalli, Andrea
Cesana, Daniela https://orcid.org/0000-0001-6366-4224
Gallina, Pierangela
Pedemonte, Nicoletta https://orcid.org/0000-0002-5161-1720
Capurro, Valeria
Clementi, Nicola https://orcid.org/0000-0002-1822-9861
Mancini, Nicasio
Invernizzi, Pietro https://orcid.org/0000-0003-3262-1998
Bayarri-Olmos, Rafael https://orcid.org/0000-0003-3202-9679
Garred, Peter https://orcid.org/0000-0002-2876-8586
Rappuoli, Rino https://orcid.org/0000-0002-8827-254X
Duga, Stefano https://orcid.org/0000-0003-3457-1410
Bottazzi, Barbara https://orcid.org/0000-0002-1930-9257
Uguccioni, Mariagrazia
Asselta, Rosanna https://orcid.org/0000-0001-5351-0619
Vicenzi, Elisa https://orcid.org/0000-0003-0051-3968
Mantovani, Alberto https://orcid.org/0000-0001-5578-236X
Garlanda, Cecilia https://orcid.org/0000-0002-1510-7703
- License Information
-
More Information
Article History
Received: 21 June 2021
Accepted: 9 December 2021
First Online: 31 January 2022
Competing interests
: A.M., C.G. and B.B. are inventors of a patent (EP20182181) on PTX3 and obtain royalties on related reagents. A.M., C.G., B.B. and E.V. are inventors of two patents (102021000002738 and EP21214373.9) on MBL. R.R. is a full-time employee of the GSK group of companies. The other authors declare no competing interests.
Free to read: This content has been made available to all.
